Investors

At a $500 million valuation: Will Hapoel Tel Aviv bring in additional investors?

Calcalist reports that Hapoel Tel Aviv is seeking new investors to help fund its EuroLeague license and a new arena, potentially reducing current ownership in Yannay Sport to 50%.

Ofer Yannay, owner of Hapoel Tel Aviv.
The company urged ticket holders to decide within 12 hours whether they wanted an alternative flight on another airline with a layover or to receive a financial refund. Arkia.

Arkia employees scramble to find rival investor by Monday to counter $45 million sale deal

An illustrative image of investment in the US market.

To Israeli innovators: The US market Is still yours to win - opinion

THE TEL AVIV stock exchange. Although Israel’s economy emerged triumphant from the war, with full employment and one of the world’s strongest currencies still intact, this does not mean it can spend a tenth of its GDP on defense, the writer maintains.

Investors see economic upside for Israel if opposition beats Netanyahu in upcoming elections


Investing in Israel's immigrants: New VC firm offers olim up to $500k. in funding for startups

Aliyah Ventures emerged from stealth with the objective of funding projects by new immigrants in Israel, targeting a portfolio of 30-40 companies.

Welcoming new olim to Israel at Ben-Gurion Airport, September 14, 2026.

A place in Israel

From Midtown Jerusalem to a more connected Israel (property.com): Journey.

Connecting buyers, properties and professionals to simplify the journey to an Israeli home.

Greece plans to quintuple purchase tax for foreign real estate buyers

The Greek prime minister announced plans to raise the purchase tax for non-EU real estate investors from 3% to 15%.

The Parthenon temple without scaffolding for the first time in 200 years, October 17, 2025.

Your Investments: One sea, many portfolios

Building the right investment portfolio starts with understanding your goals, time horizon, and tolerance for risk, not following the latest stock market trends or investment tips.

AMERICAN WRITER Ernest Hemingway (1899-1961) travels with US soldiers on their way to Normandy for the D-Day landings, in his capacity as war correspondent, in 1944.

Remote renovations: How Israeli investors can successfully upgrade UK properties

Managing UK property upgrades from Israel is easier than ever - here’s how to stay in control and maximize return.

"Investing abroad doesn’t mean losing control - smart remote management ensures your UK property is market-ready from thousands of miles away."

Warren Buffett steps down as Berkshire chair, becomes chairman emeritus

Howard Buffett will chair the $1 trillion conglomerate as his father remains on its board in an advisory role.

Berkshire Hathaway Chairman Warren Buffett walks through the exhibit hall as shareholders gather to hear from the billionaire investor at Berkshire Hathaway Inc's annual shareholder meeting in Omaha, Nebraska, US, May 4, 2019; illustrative.

Former UTrade chief analyst Roy Cuzin convicted in NIS 77 million investor fraud case

The prosecution and defense will jointly ask the court to sentence Cuzin to 22 months in prison and impose a NIS 25,000 fine.

The law courts in Tel Aviv

OpenAI commits $1 billion to cyberdefense effort amid growing AI safety scrutiny

OpenAI on Thursday, alongside the cybersecurity initiative, also unveiled Astra, a new AI model it described as its most capable yet but said can at times attempt to evade human monitoring.

Sam Altman, CEO of OpenAI.

Firm led by first Israeli NBA player Omri Casspi opens new $250 million fund for high-tech startups

The announcement made by Casspi's firm, Swish Ventures, says that the funding will focus on 12 high-tech startups with an average value of $20 million each.

Omri Casspi #18 of the Memphis Grizzlies dunks the ball during a game against the Boston Celtics at TD Garden on January 18, 2019 in Boston, Massachusetts.

Stock crashed: Company that concealed information from investors slapped with fine

Epitomee Medical fined NIS 1.85m for hiding data that ended a major Nestle deal, crashing its stock after misleading reports on clinical success.

A clinical success, a hidden failure, and a NIS 1.85 million price tag for misleading the market.